Government
Sep. 11, 2007
Patent Bill Passes House, but Debate Over Damages Continues
A wide-ranging patent reform bill may be half way through Congress, but lawmakers have so far failed to resolve the most controversial issue. With debate now moving from the House to the Senate, the technology and pharmaceutical sectors are still at odds over the best way to calculate damages
Daily Journal Staff Writer
WASHINGTON - A wide-ranging patent reform bill may be half way through Congress, but lawmakers have so far failed to resolve the most controversial issue.
Even when the House passed its version of the bill Friday, the legislation's leading supporters had to shore up support by promising further compromise over changes to the way damage...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In